Biotest Aktiengesellschaft (ETR:BIO – Get Free Report)’s stock price dropped 0.5% on Thursday . The stock traded as low as €41.20 ($42.47) and last traded at €41.20 ($42.47). Approximately 46 shares were traded during trading, a decline of 98% from the average daily volume of 1,927 shares. The stock had previously closed at €41.40 ($42.68).
Biotest Aktiengesellschaft Price Performance
The company has a debt-to-equity ratio of 116.50, a quick ratio of 1.66 and a current ratio of 2.45. The company’s 50 day moving average price is €41.46 and its 200-day moving average price is €41.65. The company has a market cap of $815.35 million, a price-to-earnings ratio of 9.93 and a beta of 0.24.
About Biotest Aktiengesellschaft
Biotest Aktiengesellschaft develops, manufactures, and sells biological and biotechnological pharmaceutical products in Germany and internationally. It operates through three segments: European Union, Rest of the World, and Stateless. The company specializes primarily in the therapeutic areas of clinical immunology, haematology, and intensive care medicine.
Featured Stories
- Five stocks we like better than Biotest Aktiengesellschaft
- Investing in Construction Stocks
- 3 Legacy Tech Companies Reemerging as AI LeadersÂ
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Analysts’ Favorite Cybersecurity Stocks: 3 Top Picks
- High Flyers: 3 Natural Gas Stocks for March 2022
- Analysts Are Bullish: 3 Tech Giants With Upgraded Price Targets
Receive News & Ratings for Biotest Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotest Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.
